Cargando…
Following the Preclinical Data: Leveraging the Abscopal Effect More Efficaciously
Radiotherapy is employed in the treatment of over 50% of cancer patients. However, this therapy approach is limited to mainly treating localized disease. In 1953, Mole described the remarkable abscopal effect, whereby, localized radiotherapy of a patient’s primary tumor might engender regression of...
Autores principales: | Ngwa, Wilfred, Ouyang, Zi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388832/ https://www.ncbi.nlm.nih.gov/pubmed/28447024 http://dx.doi.org/10.3389/fonc.2017.00066 |
Ejemplares similares
-
Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants
por: Moreau, Michele, et al.
Publicado: (2018) -
Enhancing the Bystander and Abscopal Effects to Improve Radiotherapy Outcomes
por: Farias, Virgínea de Araújo, et al.
Publicado: (2020) -
Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity
por: Lai, Jin-Zhi, et al.
Publicado: (2021) -
Systemic benefit of radiation therapy via abscopal effect
por: Craig, Daniel J., et al.
Publicado: (2022) -
Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma
por: Brenneman, Randall J., et al.
Publicado: (2019)